Gluten News and Research

RSS

Study: About one-third of gluten-free foods tested positive for presence of gluten

Even tiny amounts of gluten in foods are troublesome for people with celiac disease, and restaurants may be the hardest places to avoid the protein, finds a study by Benjamin Lebwohl, MD, MS, Celiac Disease Center at NY-Presbyterian Hospital and assistant professor of medicine and epidemiology at Columbia Mailman School.

8 Apr 2019

Canadian maple syrup can be used as energy source during endurance exercise

Canadian maple syrup provides a pure energy source for endurance athletes and can help fight inflammation, according to new research published today.

3 Apr 2019

Study shows how some autoimmune diseases are more closely related than others

Researchers using the world's largest twin registry to study seven autoimmune diseases found the risk of developing the seven diseases is largely inherited, but that some diseases are more closely related than others.

25 Mar 2019

Novel breath test could pave new way to non-invasively measure gut health

Small children may one day avoid invasive, painful and often traumatic oesophageal tube-testing for gut damage and coeliac disease with a new method of simply blowing into a glass tube to provide effective diagnoses.

20 Mar 2019

Most pills contain common allergens, warn experts

Pills or oral medications contain inactive ingredients such as gluten that may be responsible for dangerous side effects, concludes a new study.

20 Mar 2019

Gluten, lactose, food dyes in pills could be causing side effects finds study

Pills or oral medications contain inactive ingredients. Some of these may be responsible for the side effects says a new study. The study results appeared in an article published in the latest issue of the journal Science Translational Medicine.

18 Mar 2019

Celiac disease may be caused by gastrointestinal infection in childhood

A new study has found that a childhood stomach bug may be the cause of celiac disease later in life. The findings could pave the way for a vaccine to protect against the disease.

15 Feb 2019

Religious beliefs influence consumer choices on specialty foods

People with strong religious beliefs are more likely to buy fat-free, sugar-free or gluten-free foods than natural or organic foods, according to new research that could influence the marketing of those specialty food products.

5 Feb 2019

Gluten-free wheat can be produced for people with celiac disease by using gene editing

One to two per cent of the population has Celiac Disease (CD), an immune reaction to gluten. Wheat grains contain gluten, a mixture of glutenin and gliadin proteins, which build a network that gives wheat bread its unique properties and quality.

28 Jan 2019

High-protein rice can help solve global problem across social, cultural, and economic issues

More than 750 million people don't get enough nutrients from their food. More than two-thirds of those people live in places that consume a lot of rice. Can rice bred for extra protein be the answer?

23 Jan 2019

Common food additive could cause celiac disease, review says

Research suggests that celiac disease could be caused by a bacterial enzyme used to manufacture sausages, cheese, bread and other processed foods.

7 Jan 2019

Prebiotic supplement may be effective alternative to reduce GI disturbances in autistic children

Diets free from gluten and casein are often recommended as a way to reduce gastrointestinal (GI) problems in children with autistic spectrum disorders.

22 Nov 2018

Live probiotics can change existing gut flora and alter immune response

New research published in the International Journal of Pharmaceutics demonstrates that 'good' bacteria in the live probiotic SymproveTM can successfully reach and colonize the gut, where they go on to change the existing gut flora. They are also capable of modifying immune response.

20 Nov 2018

Researchers explore whether low-gluten diets can be recommended for people without allergies

An increasing number of people choose a low-gluten diet, even though they are not allergic to the dietary substance. This trend has sparked public debate about whether or not low-gluten diets are recommendable for people without allergies.

15 Nov 2018

New method helps study connection between metabolism in gut bacteria and development of diabetes

Researchers at örebro University have, together with a well-known research team in Denmark, developed a method for studying how metabolism in gut bacteria influences our health. Their method will now be published in its entirety in the scientific journal Nature Protocols.

7 Nov 2018

World’s first vaccine against coeliac disease to be tested in Australia

US-based pharmaceutical company ImmusanT, after worldwide trials, is all set to start clinical trials of a new vaccine against coeliac disease at the Royal Melbourne Hospital Clinical Trials Centre in Melbourne. This will be followed by trials to be held at Adelaide, Brisbane, Perth, Mackay and Sunshine Coast say the sources.

31 Oct 2018

UK set to fortify flour with folic acid to prevent spine defects among newborns

Public Health Minister Steve Brine added that the move would be discussed with the ministers and is likely to raise folic acid consumption among pregnant mothers.

24 Oct 2018

Researchers study how proliferation of gluten-free industry affects people with celiac disease

A new Journal of Human Nutrition and Dietetics study has investigated how the recent proliferation of the gluten-free industry has affected individuals living with celiac disease.

3 Oct 2018

TU Wien develops new remedy for celiac disease

Celiac disease is a fairly common disease, affecting one to two percent of the European population. It is expressed as a hypersensitivity to gluten, a protein found in cereals such as wheat, barley or rye.

24 Sep 2018

ImmusanT receives JDRF T1D Fund to develop novel vaccine candidate for type 1 diabetes

ImmusanT, Inc., a clinical stage company that is leveraging its Epitope-Specific Immuno-Therapy™ platform to translate and deliver first-in-class peptide-based immune therapies to people living with autoimmune diseases, today announced that it has received an investment from the JDRF T1D Fund, a venture philanthropy fund exclusively devoted to finding and funding the best type 1 diabetes commercial opportunities.

11 Sep 2018